Test de dépistage rapide du VIH falsifié circulant dans les régions OMS des Amériques et de l’Afrique
This Medical Product Alert relates to a confirmed falsified human immunodeficiency virus (HIV) in vitro diagnostic medical device (IVD) that has been identified circulating in Guyana and Kenya.
Through its Global Surveillance and Monitoring System (GSMS) for substandard/falsified medical products, WHO was informed that at least 8,240 falsified rapid diagnostic tests to detect HIV-1/2 have been distributed in Guyana at end-user level. The product is Uni-Gold™ HIV and claims to be manufactured by Trinity Biotech plc. Subsequent reports revealed that the same falsified product is also circulating in Kenya.
Uni-Gold™ HIV is a single-use rapid diagnostic test – an immunoassay for the qualitative detection of antibodies to HIV-1 and HIV-2 in serum, plasma and whole blood. Uni-Gold™ HIV is intended for use in point of care settings as an aid in diagnosis of HIV-1 and HIV-2 infection.
The WHO testing strategy recommends three HIV reactive test results to confirm an HIV-positive status in a patient. The use of this falsified Uni-Gold™ HIV, subject of WHO medical product alert n°2 of 2020, is likely to lead to delayed diagnosis of HIV status.
Table 1: Specific details of the falsified product Uni-Gold™ HIV, subject of WHO Medical Product Alert n°2 of 2020
5 DEC 2020
|29 JUL 20|
The packaging of this falsified HIV test kit is in English.
The genuine manufacturer (Trinity Biotech plc) has confirmed that:
- They did not manufacture the falsified product in Table 1.
- Genuine lot HIV7120026 and HIV6120030 was made by Trinity Biotech plc and expired in 2019.
- The expiry date is incorrect and does not correspond with their batch manufacturing records.
Photographs of the above-referenced products are available on page 2 and advice to the public is available on page 3.
Figure 1 – Falsified Uni-Gold™ HIV, lot number HIV7120026, displaying falsified expiry date
Figure 2 – Falsified Uni-Gold™ HIV, displaying labelling inconsistencies
Figure 3 – Falsified Uni-Gold™ HIV, lot number HIV6120030, displaying falsified expiry date
Advice on action to be taken by end-users:
- Please check to see if any Uni-Gold™ HIV test kits in your facility have lot number HIV7120026 or HIV6120030.
- If you are in possession of these falsified test kits with lot number HIV7120026 or HIV6120030.
Please do not use.
- Please immediately contact the organization that supplied you with the product (either your HIV testing programme, nongovernmental organization or local distributor).
- Please contact Trinity Biotech plc
Phone : +353 1 276 9800
E-mail : email@example.com
- Please contact your national health authorities
All medical products must be obtained from authentic and reliable sources. Their authenticity and condition should be carefully checked.
Advice on action to be taken by national health authorities:
WHO requests increased scrutiny within the supply chains of all countries, particularly at testing sites (health facilities, community-based), clinical laboratories, medical stores/warehouses, and at the facilities of relevant economic operators (agents,
authorized representatives, distributors, wholesalers, etc.).
If falsified test kits with lot numbers HIV7120026 or HIV6120030 are discovered, please do not use.
National health authorities are asked to immediately inform WHO, if these falsified products are discovered in their country using the WHO IVD complaint form.
If you have any information concerning the manufacture, distribution, or supply of this product, please contact firstname.lastname@example.org
WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/